# ETFs That Hold Neuren Pharmaceuticals Ltd (NEU)

> 27 thematic and core ETFs hold Neuren Pharmaceuticals Ltd (NEU). ASD holds the most, at 2.80% of the fund on Nov 19, 2026.

Data as of Nov 21, 2026. Rebuilt every trading night.

## ETFs that hold Neuren Pharmaceuticals Ltd

27 thematic and core ETFs hold Neuren Pharmaceuticals Ltd , by holdings dated Jul 31, 2026 to Nov 19, 2026 . ASD holds the most, at 2.80% of the fund on Nov 19, 2026 . The next largest are IBRN (2.53%) and ISCF (0.12%).

### Thematic and core funds that hold it

| Fund | Name | Share of the fund | Holdings filed | Asset |
| --- | --- | --- | --- | --- |
| ASD | Defiance Autism Impact ETF | 2.80% | Nov 19, 2026 | Equity |
| IBRN | iShares Neuroscience and Healthcare ETF | 2.53% | Nov 13, 2026 | Equity |
| ISCF | iShares International Small-Cap Equity Factor ETF | 0.12% | Nov 19, 2026 | Equity |
| AVDS | Avantis International Small Cap Equity ETF | 0.07% | Nov 17, 2026 | Equity |
| SCHC | Schwab International Small-Cap Equity ETF | 0.06% | Aug 31, 2026 | Equity |
| AVDV | Avantis International Small Cap Value ETF | 0.05% | Nov 17, 2026 | Equity |
| SCZ | iShares MSCI EAFE Small-Cap ETF | 0.05% | Nov 19, 2026 | Equity |
| VSS | Vanguard FTSE All-Wld ex-US SmCp Idx ETF | 0.04% | Oct 31, 2026 | Equity |
| DFIS | Dimensional International Small Cap ETF | 0.03% | Jul 31, 2026 | Equity |
| IPAC | iShares Core MSCI Pacific ETF | 0.02% | Nov 19, 2026 | Equity |
| WSML | iShares MSCI World Small-Cap ETF | 0.02% | Nov 19, 2026 | Equity |
| DXIV | Dimensional International Vector Equity ETF | 0.01% | Jul 31, 2026 | Equity |
| VPL | Vanguard FTSE Pacific ETF | 0.01% | Oct 31, 2026 | Equity |
| AVDE | Avantis International Equity ETF | 0.01% | Nov 17, 2026 | Equity |
| IDEV | iShares Core MSCI International Developed Markets ETF | 0.01% | Nov 19, 2026 | Equity |
| IEFA | iShares Core MSCI EAFE ETF | 0.01% | Nov 19, 2026 | Equity |
| DFSI | Dimensional International Sustainability Core 1 ETF | 0.01% | Jul 31, 2026 | Equity |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.01% | Aug 31, 2026 | Equity |
| SPDW | State Street SPDR Portfolio Developed World ex-US ETF | 0.01% | Nov 19, 2026 | Equity |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% | Nov 19, 2026 | Equity |
| VEA | Vanguard FTSE Developed Markets ETF | 0.01% | Oct 31, 2026 | Equity |
| VSGX | Vanguard ESG International Stock ETF | 0.01% | Oct 31, 2026 | Equity |
| DFAI | Dimensional International Core Equity Market ETF | Neuren Pharmaceuticals Ltd (ticker NEU, listed in NZ) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.

Each row shows the date the fund last filed.

Look up another company .

### Questions people ask

Which ETFs hold Neuren Pharmaceuticals Ltd? 27 thematic and core ETFs hold Neuren Pharmaceuticals Ltd, by holdings dated Jul 31, 2026 to Nov 19, 2026. The largest positions are ASD at 2.80% of the fund on Nov 19, 2026, IBRN at 2.53% of the fund on Nov 13, 2026 and ISCF at 0.12% of the fund on Nov 19, 2026.

---

Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.
Cite: ETFIQ, ETFs holding Neuren Pharmaceuticals Ltd, data as of Nov 21, 2026. https://etfiq.com/holdings/neuren-pharmaceuticals-ltd/
Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.
HTML: https://etfiq.com/holdings/neuren-pharmaceuticals-ltd/
